Hospital
Berwick Hospital Company LLC
Berwick Hospital Company LLC was paid $479K by Medicaid between Dec 2019 and Sep 2022, across 61 billing codes. Its largest line is 99283, emergency room visit (moderate) — 27% of everything it billed.
33Billing provider infoBERWICK HOSPITAL COMPANY LLC
BERWICK, PA 18603
BERWICK, PA 18603
33aNPI1316919699assigned 02/02/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$479K
24GClaims19,504
24DCodes billed61
24AFirst – last monthDec 2019 – Sep 2022
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#110 of 154
Median peer was paid$2.82M
This provider vs. median0.2×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 12 | $395.00 | |
| 2020 | 2,588 | $60K | |
| 2021 | 13,978 | $315K | |
| 2022 | 2,926 | $103K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 2,211 | 2,151 | $132K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 1,296 | 1,249 | $92K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5.1% | 678 | 655 | $24K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 4.3% | 290 | 284 | $20K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.6% | 210 | 203 | $17K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.3% | 215 | 210 | $16K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.3% | 200 | 185 | $16K |
| 80053 | Comprehensive metabolic panel | 3.2% | 1,490 | 1,427 | $15K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 385 | 380 | $15K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.6% | 422 | 405 | $12K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.4% | 2,320 | 2,141 | $12K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.2% | 478 | 475 | $10K |
49 more codes
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 2.0% | 23 | $10K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.0% | 167 | $10K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.8% | 349 | $9K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.5% | 638 | $7K |
| 80061 | Lipid panel | 1.2% | 436 | $6K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.2% | 222 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 616 | $4K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 209 | $4K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 523 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 306 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 244 | $3K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 162 | $3K |
| 84703 | <1% | 328 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 375 | $2K |
| 84484 | <1% | 339 | $2K | |
| 93970 | <1% | 27 | $2K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 25 | $2K |
| 81003 | <1% | 721 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 231 | $1K |
| 84439 | <1% | 186 | $1K | |
| 83735 | <1% | 267 | $1K | |
| 71045 | Radiologic examination, chest; single view | <1% | 203 | $1K |
| 83690 | <1% | 242 | $1K | |
| 85610 | <1% | 327 | $935.06 | |
| 82150 | <1% | 156 | $727.07 | |
| 85730 | <1% | 140 | $690.35 | |
| 83880 | <1% | 30 | $572.68 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 13 | $519.61 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 217 | $479.99 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 50 | $439.43 |
| 36415 | Collection of venous blood by venipuncture | <1% | 340 | $415.81 |
| 73630 | <1% | 40 | $411.30 | |
| 73610 | <1% | 24 | $396.12 | |
| 85027 | <1% | 57 | $355.80 | |
| 87077 | <1% | 74 | $352.79 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 422 | $327.38 |
| 80076 | <1% | 40 | $315.24 | |
| 73564 | <1% | 14 | $288.08 | |
| 85379 | <1% | 32 | $256.53 | |
| 84481 | <1% | 12 | $246.97 | |
| 87040 | <1% | 22 | $147.00 | |
| 87186 | <1% | 27 | $141.13 | |
| 81005 | <1% | 46 | $134.27 | |
| 87070 | <1% | 16 | $92.85 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 303 | $63.56 |
| 85651 | <1% | 13 | $40.50 | |
| J2704 | Injection, propofol, 10 mg | <1% | 15 | $32.64 |
| 82962 | <1% | 28 | $18.70 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 12 | $6.11 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.